BSACI guideline for the set‐up of penicillin allergy de‐labelling services by non‐allergists working in a hospital setting

AbstractThe Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI) and a committee of experts and key stakeholders have developed this guideline for the evaluation and testing of patients with an unsubstantiated label of penicillin allergy. The guideline is intended for UK clinicians who are not trained in allergy or immunology, but who wish to develop a penicillin allergy de‐labelling service for their patients. It is intended to supplement the BSACI 2015 guideline “Management of allergy to penicillin and other beta‐lactams” and therefore does not detail the epidemiology or aetiology of penicillin allergy, as this is covered extensively in the 2015 guideline (1). The guideline is intended for use only in patients with a label of penicillin allergy and does not apply to other beta‐lactam allergies. The recommendations include a checklist to identify patients at low risk of allergy and a framework for the conduct of drug provocation testing by non‐allergists. There are separate sections for adults and paediatrics within the guideline, in recognition of the common differences in reported allergy history and likelihood of true allergy.

Topics

No keywords indexed for this article. Browse by subject →

References

29

[1]

10.1093/jac/dkz127

[2]

Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort study

Eric Macy, Richard Contreras

Journal of Allergy and Clinical Immunology 10.1016/j.jaci.2013.09.021

[3]

10.1016/j.bja.2020.07.048

[4]

10.1016/j.jaip.2013.02.002

[5]

10.1016/j.jaip.2019.04.006

[6]

10.1136/bmj.k2400

[7]

10.1016/j.arth.2021.04.032

[8]

10.1016/j.jaip.2017.12.033

[9]

10.1093/cid/ciaa194

[10]

10.1016/j.arth.2020.08.045

[11]

10.18176/jiaci.0457

[12]

Royal Coll Physicians (2003)

[13]

10.1136/bmj.g4852

[14]

InternationalConsensus on drug allergy

P. Demoly, N. F. Adkinson, K. Brockow et al.

Allergy 10.1111/all.12350

[15]

10.1016/j.jaip.2017.01.023

[16]

10.1016/j.jaip.2018.05.008

[17]

10.1093/jac/dky575

[18]

10.1016/j.bja.2018.09.009

[19]

10.1093/cid/ciaa653

[20]

https://www.resus.org.uk/about‐us/news‐and‐events/rcuk‐guidelines‐2021‐published

[21]

10.1111/cea.12468

[22]

10.1111/cea.13707

[23]

10.1016/j.jaci.2010.08.025

[24]

10.1111/j.1365-2222.2007.02870.x

[25]

10.1542/peds.2007-3178

[26]

10.1001/jamapediatrics.2016.0033

[27]

10.1111/jpc.14220

[28]

Chigullapalli S "Parents and primary care perspectives on penicillin de‐labelling in children" Clin Exp Allergy (2021)

[29]

10.1016/j.jaip.2021.01.005

Cited By

75

ESCMID clinical guidelines on the evaluation and management of a reported antibiotic allergy

Oana Joean, Kevin Sermet · 2026

Clinical Microbiology and Infection

Metrics

75

Citations

29

References

Details

Published: Sep 21, 2022
Vol/Issue: 52(10)
Pages: 1135-1141
License: View

Authors

L

Louise Savic

Department of Anaesthesia Leeds Teaching Hospitals NHS Trust Leeds UK

M

Michael Ardern‐Jones

Faculty of Medicine University of Southampton Southamptom UK; Department of Dermatology University Hospitals Southampton NHS Foundation Trust Southamptom UK

A

Anthony Avery

Centre for Academic Primary Care, School of Medicine University of Nottingham Nottingham UK

T

Tim Cook

Department of Anaesthesia and Intensive Care Royal United Hospitals Bath NHS Foundation Trust Bath UK

S

Sarah Denman

Medicines Management and Pharmacy Services Leeds Teaching Hospitals NHS Trust Leeds UK

S

Sophie Farooque

Department of Allergy Imperial College Healthcare NHS Trust London UK

T

Tomaz Garcez

Dept of Immunology Manchester University NHS Foundation Trust Manchester UK

R

Rochelle Gold

Patient Representative

N

Nicola Jay

Department of Paediatric Allergy Sheffield Childrens NHS Foundation Trust Sheffield UK

M

Mamidipudi Thirumala Krishna

Department of Allergy and Immunology University Hospitals Birmingham NHS Foundation Trust Birmingham UK; Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK

S

Sue Leech

Department of Paedaitric Allergy Kings College Hospital NHS Foundation Trust London UK

S

Shauna McKibben

Department of Asthma and Allergy Imperial College Healthcare NHS Trust London UK

S

Shuaib Nasser

Department of Allergy Cambridge University Hospitals NHS Foundation Trust Cambridge UK

N

Nikhil Premchand

Department of Clinical Infection Northumbria Healthcare NHS Foundation Trust Newcastle UK

J

Jonathan Sandoe

Leeds Institute of Medical Research University of Leeds Leeds UK; Department of Microbiology Leeds Teaching Hospitals NHS Trust Leeds UK

J

Jacqueline Sneddon

British Society for Antimicrobial Chemotherapy Birmingham UK; Health Improvement Scotland Glasgow UK

A

Amena Warner

Allergy UK Leeds UK

Cite This Article

Louise Savic, Michael Ardern‐Jones, Anthony Avery, et al. (2022). BSACI guideline for the set‐up of penicillin allergy de‐labelling services by non‐allergists working in a hospital setting. Clinical & Experimental Allergy, 52(10), 1135-1141. https://doi.org/10.1111/cea.14217

BSACI guideline for the set‐up of penicillin allergy de‐labelling services by non‐allergists working in a hospital setting

You May Also Like